An
improved process for the large scale synthesis of 1-{[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide
(1), a candidate currently in clinical development, was
developed. Key objectives were to eliminate chromatographic purifications,
to maximize the reproducibility of each step, and to improve the yield
and efficiency of each step relative to the previous discovery syntheses
of 1. This work was focused on improvements to the synthesis
of the stereochemically complex lactam 2. Steps of particular
concern were the preparation of the unsaturated lactam 6, the cuprate conjugate addition reaction to produce 7, and the conversion of 7 to 8 with a high
degree of diastereoselection. The solutions to these challenges have
permitted the synthesis of 2 in excess of 100 kg, which
in turn has permitted 1 to be prepared in sufficient
amounts to support further development.